C17 Developmental Therapeutics Committee
Under the leadership of Co-chairs Daniel Morgenstern and Chris Maxwell, the C17 DVL Committee provides greater access across Canada to Phase I/II trials; allowing children and their families an option for investigational treatments while staying closer to home. There are now eleven C17 centres participating, providing access across Canada for children eligible for these studies.
The C17 DVL Committee, in partnership with CCTG, opened the first study in September 2010. Several DVL studies have now been funded by C17 and are either in development, in discussion with pharmaceutical companies, or are identified as potential studies for pediatric oncology based on early adult work.
DVL Phase I/II sites
- Alberta Children's Hospital (Calgary)
- BC Children's Hospital (Vancouver)
- CancerCare Manitoba (Winnipeg)
- Children's Hospital (London)
- Children’s Hospital of Eastern Ontario (Ottawa)
- CHU Sainte Justine (Montreal)
- Hospital for Sick Children (Toronto)
- IWK Health Centre (Halifax)
- Janeway Child health Centre (St. John's)
- McMaster Children's Hospital (Hamilton)
- Stollery Children’s Hospital (Edmonton)
- Montreal Children's Hospital (Montreal)
- CHU de Quebec (Quebec City)